A process for inhibiting microbial growth comprising administering a formulation comprising a
pyridinium chloride compound of Formula (I), described herein, wherein R1- R6, independently comprise
hydrogen, substituted or unsubstituted C1 to C24
alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted
aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl,
sulfonate,
aryl sulfonate, C1 to C24
alkyl sulfonate,
taurine,
carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide,
halogen, hydroxy,
amide, nitro, cyano,
azide, O-
alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl,
trifluoromethyl,
hydrazide, substituted or unsubstituted
aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl,
amide,
amino acid, or
peptide; and X and Y independently comprise a
heteroatom selected from
oxygen,
nitrogen, or
sulfur, or a heterocarbyl comprising one or heteroatoms selected from
oxygen,
nitrogen, or
sulfur.